Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
Identifieur interne : 003652 ( Ncbi/Curation ); précédent : 003651; suivant : 003653Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
Auteurs : Silke Tribius [Allemagne] ; Stefanie Kronemann ; Yasemin Kilic ; Ursula Schroeder ; Samer Hakim ; Steven E. Schild ; Dirk RadesSource :
- Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [ 1439-099X ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Analyse de survie, Association thérapeutique, Calendrier d'administration des médicaments, Carcinome épidermoïde (anatomopathologie), Carcinome épidermoïde (mortalité), Carcinome épidermoïde (radiothérapie), Carcinome épidermoïde (traitement médicamenteux), Cisplatine (administration et posologie), Cisplatine (effets indésirables), Femelle, Fluorouracil (administration et posologie), Fluorouracil (effets indésirables), Fractionnement de la dose d'irradiation, Humains, Lésions radio-induites (étiologie), Mâle, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Stade de la tumeur, Survie sans rechute, Traitement médicamenteux adjuvant, Tumeurs oto-rhino-laryngologiques (anatomopathologie), Tumeurs oto-rhino-laryngologiques (mortalité), Tumeurs oto-rhino-laryngologiques (radiothérapie), Tumeurs oto-rhino-laryngologiques (traitement médicamenteux), Études de suivi, Études rétrospectives.
- MESH :
- administration et posologie : Cisplatine, Fluorouracil.
- anatomopathologie : Carcinome épidermoïde, Tumeurs oto-rhino-laryngologiques.
- effets indésirables : Cisplatine, Fluorouracil, Protocoles de polychimiothérapie antinéoplasique.
- mortalité : Carcinome épidermoïde, Tumeurs oto-rhino-laryngologiques.
- radiothérapie : Carcinome épidermoïde, Tumeurs oto-rhino-laryngologiques.
- traitement médicamenteux : Carcinome épidermoïde, Tumeurs oto-rhino-laryngologiques.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- étiologie : Lésions radio-induites.
- Adulte d'âge moyen, Analyse de survie, Association thérapeutique, Calendrier d'administration des médicaments, Femelle, Fractionnement de la dose d'irradiation, Humains, Mâle, Stade de la tumeur, Survie sans rechute, Traitement médicamenteux adjuvant, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Antineoplastic Combined Chemotherapy Protocols (adverse effects), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Carcinoma, Squamous Cell (drug therapy), Carcinoma, Squamous Cell (mortality), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (radiotherapy), Chemotherapy, Adjuvant, Cisplatin (administration & dosage), Cisplatin (adverse effects), Combined Modality Therapy, Disease-Free Survival, Dose Fractionation, Drug Administration Schedule, Female, Fluorouracil (administration & dosage), Fluorouracil (adverse effects), Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Staging, Otorhinolaryngologic Neoplasms (drug therapy), Otorhinolaryngologic Neoplasms (mortality), Otorhinolaryngologic Neoplasms (pathology), Otorhinolaryngologic Neoplasms (radiotherapy), Radiation Injuries (etiology), Retrospective Studies, Survival Analysis.
- MESH :
- chemical , administration & dosage : Cisplatin, Fluorouracil.
- adverse effects : Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Fluorouracil.
- drug therapy : Carcinoma, Squamous Cell, Otorhinolaryngologic Neoplasms.
- etiology : Radiation Injuries.
- mortality : Carcinoma, Squamous Cell, Otorhinolaryngologic Neoplasms.
- pathology : Carcinoma, Squamous Cell, Otorhinolaryngologic Neoplasms.
- radiotherapy : Carcinoma, Squamous Cell, Otorhinolaryngologic Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Chemotherapy, Adjuvant, Combined Modality Therapy, Disease-Free Survival, Dose Fractionation, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Staging, Retrospective Studies, Survival Analysis.
Abstract
The optimal radiochemotherapy regimen for advanced head-and-neck cancer is still debated. This nonrandomized study compares two cisplatin-based radiochemotherapy regimens in 128 patients with locally advanced unresectable stage IV squamous cell carcinoma of the head and neck (SCCHN).
DOI: 10.1007/s00066-009-1992-x
PubMed: 19806333
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002D24
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002D24
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002D24
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003652
Links to Exploration step
pubmed:19806333Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.</title>
<author><name sortKey="Tribius, Silke" sort="Tribius, Silke" uniqKey="Tribius S" first="Silke" last="Tribius">Silke Tribius</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg</wicri:regionArea>
<placeName><settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kronemann, Stefanie" sort="Kronemann, Stefanie" uniqKey="Kronemann S" first="Stefanie" last="Kronemann">Stefanie Kronemann</name>
</author>
<author><name sortKey="Kilic, Yasemin" sort="Kilic, Yasemin" uniqKey="Kilic Y" first="Yasemin" last="Kilic">Yasemin Kilic</name>
</author>
<author><name sortKey="Schroeder, Ursula" sort="Schroeder, Ursula" uniqKey="Schroeder U" first="Ursula" last="Schroeder">Ursula Schroeder</name>
</author>
<author><name sortKey="Hakim, Samer" sort="Hakim, Samer" uniqKey="Hakim S" first="Samer" last="Hakim">Samer Hakim</name>
</author>
<author><name sortKey="Schild, Steven E" sort="Schild, Steven E" uniqKey="Schild S" first="Steven E" last="Schild">Steven E. Schild</name>
</author>
<author><name sortKey="Rades, Dirk" sort="Rades, Dirk" uniqKey="Rades D" first="Dirk" last="Rades">Dirk Rades</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19806333</idno>
<idno type="pmid">19806333</idno>
<idno type="doi">10.1007/s00066-009-1992-x</idno>
<idno type="wicri:Area/PubMed/Corpus">002D24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D24</idno>
<idno type="wicri:Area/PubMed/Curation">002D24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D24</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002D24</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002D24</idno>
<idno type="wicri:Area/Ncbi/Merge">003652</idno>
<idno type="wicri:Area/Ncbi/Curation">003652</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.</title>
<author><name sortKey="Tribius, Silke" sort="Tribius, Silke" uniqKey="Tribius S" first="Silke" last="Tribius">Silke Tribius</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg</wicri:regionArea>
<placeName><settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kronemann, Stefanie" sort="Kronemann, Stefanie" uniqKey="Kronemann S" first="Stefanie" last="Kronemann">Stefanie Kronemann</name>
</author>
<author><name sortKey="Kilic, Yasemin" sort="Kilic, Yasemin" uniqKey="Kilic Y" first="Yasemin" last="Kilic">Yasemin Kilic</name>
</author>
<author><name sortKey="Schroeder, Ursula" sort="Schroeder, Ursula" uniqKey="Schroeder U" first="Ursula" last="Schroeder">Ursula Schroeder</name>
</author>
<author><name sortKey="Hakim, Samer" sort="Hakim, Samer" uniqKey="Hakim S" first="Samer" last="Hakim">Samer Hakim</name>
</author>
<author><name sortKey="Schild, Steven E" sort="Schild, Steven E" uniqKey="Schild S" first="Steven E" last="Schild">Steven E. Schild</name>
</author>
<author><name sortKey="Rades, Dirk" sort="Rades, Dirk" uniqKey="Rades D" first="Dirk" last="Rades">Dirk Rades</name>
</author>
</analytic>
<series><title level="j">Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</title>
<idno type="eISSN">1439-099X</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Carcinoma, Squamous Cell (drug therapy)</term>
<term>Carcinoma, Squamous Cell (mortality)</term>
<term>Carcinoma, Squamous Cell (pathology)</term>
<term>Carcinoma, Squamous Cell (radiotherapy)</term>
<term>Chemotherapy, Adjuvant</term>
<term>Cisplatin (administration & dosage)</term>
<term>Cisplatin (adverse effects)</term>
<term>Combined Modality Therapy</term>
<term>Disease-Free Survival</term>
<term>Dose Fractionation</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Fluorouracil (adverse effects)</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Otorhinolaryngologic Neoplasms (drug therapy)</term>
<term>Otorhinolaryngologic Neoplasms (mortality)</term>
<term>Otorhinolaryngologic Neoplasms (pathology)</term>
<term>Otorhinolaryngologic Neoplasms (radiotherapy)</term>
<term>Radiation Injuries (etiology)</term>
<term>Retrospective Studies</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Association thérapeutique</term>
<term>Calendrier d'administration des médicaments</term>
<term>Carcinome épidermoïde (anatomopathologie)</term>
<term>Carcinome épidermoïde (mortalité)</term>
<term>Carcinome épidermoïde (radiothérapie)</term>
<term>Carcinome épidermoïde (traitement médicamenteux)</term>
<term>Cisplatine (administration et posologie)</term>
<term>Cisplatine (effets indésirables)</term>
<term>Femelle</term>
<term>Fluorouracil (administration et posologie)</term>
<term>Fluorouracil (effets indésirables)</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Lésions radio-induites (étiologie)</term>
<term>Mâle</term>
<term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Stade de la tumeur</term>
<term>Survie sans rechute</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs oto-rhino-laryngologiques (anatomopathologie)</term>
<term>Tumeurs oto-rhino-laryngologiques (mortalité)</term>
<term>Tumeurs oto-rhino-laryngologiques (radiothérapie)</term>
<term>Tumeurs oto-rhino-laryngologiques (traitement médicamenteux)</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cisplatin</term>
<term>Fluorouracil</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cisplatine</term>
<term>Fluorouracil</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
<term>Cisplatin</term>
<term>Fluorouracil</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs oto-rhino-laryngologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Otorhinolaryngologic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Cisplatine</term>
<term>Fluorouracil</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Radiation Injuries</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Otorhinolaryngologic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs oto-rhino-laryngologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Otorhinolaryngologic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Otorhinolaryngologic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs oto-rhino-laryngologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs oto-rhino-laryngologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lésions radio-induites</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Chemotherapy, Adjuvant</term>
<term>Combined Modality Therapy</term>
<term>Disease-Free Survival</term>
<term>Dose Fractionation</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Retrospective Studies</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Association thérapeutique</term>
<term>Calendrier d'administration des médicaments</term>
<term>Femelle</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Mâle</term>
<term>Stade de la tumeur</term>
<term>Survie sans rechute</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The optimal radiochemotherapy regimen for advanced head-and-neck cancer is still debated. This nonrandomized study compares two cisplatin-based radiochemotherapy regimens in 128 patients with locally advanced unresectable stage IV squamous cell carcinoma of the head and neck (SCCHN).</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003652 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003652 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:19806333 |texte= Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:19806333" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |